drugset / Trial / NCT01167153

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

NCT01167153 ↗

Phase 4 Completed 564 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to compare the efficacy and safety of Valsartan/Amlodipine (EXforge®) with nifedipine, as well as vascular function index.

Timeline

Start
2010-05
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —
Comparator Nifedipine Other / unclassified 30 mg —
Subject Valsartan Unknown 80 mg —

Indications